PRECISION MEDICINE
AND THE FUTURE
OF GENOMICS
PMFG SUMMIT 2025

Vertex

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Rare Diseases, Oncology and BioPharmaceuticals including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Invest Qatar

Invest Qatar

Qatar Free Zones Authority (QFZ)

About Qatar Free Zones Authority (QFZ):

Qatar Free Zones Authority (QFZ) was established in 2018 and launched soft operations in 2020 to oversee and regulate world-class free zones in Qatar and secure fixed investments within the zones. QFZ offers outstanding opportunities and benefits for businesses seeking to establish operations and expand regionally and globally, providing quality infrastructure, a skilled workforce, 100% foreign ownership, access to investment funds, tax exemptions and partnership opportunities with Qatari entities.

For more information on QFZ, visit https://qfz.gov.qa/.

BGI Genomics

Founded in 1999, BGI is one of the world's leading life science and genomics organizations. BGI's mission is to use genomics to benefit mankind and to be a leader in the era of life sciences. BGI follows a genomics development model of "research, production and application". With businesses in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. At the same time, BGI provides equipment, technical support and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. BGI is committed to applying its genetic and technological achievements to real world settings in order to realize the dream of trans-omics for a better life.

Element Biosciences, Inc.

Element Biosciences is a life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.

Zahrawi Group

Established in 1989, Zahrawi Group is a pioneer Medical Devices and Life Science Distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in Surgical, Medical, Nuclear Medicine, Diagnostic, and Analytical Lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.

Zahrawi Group is committed to improving people’s lives by introducing innovative Healthcare products, Smart solutions, and Outstanding services.

Sedeer Medical

Established in 2001, Sedeer Medical is a Qatari total healthcare solution provider that has been at the forefront of a never-ending quest to provide the latest and the best solutions and services to its clients. Sedeer Medical has earned trust and credibility as a leading medical distributor in Qatar since its inception. Our dedication to the healthcare and scientific sectors, coupled with extensive product expertise and keen insights into market and technology trends, allows us to offer one-stop solutions tailored to our customers’ needs. As a premier medical equipment distributor, we continuously update our knowledge of new trends in the medical and scientific fields to provide the best options to our customers.
Our unbeatable presence in the market over the past 22 years has made us a powerful partner among the world’s leading scientific and healthcare brands. We represent leading brands from around the world and are partners with industry leaders. This has enabled us to maintain our position as the most preferred partner and number one solution provider in the industry.

Alliance Global

PacBio

Aamal Medical

Modern Home

About Modern Home:

In the 1940s, the Al-Darwish family offered several solutions to support the local market, including Qatar's first department store, Modern Home, established in 1949 in the Msheireb area.

With the introduction of globally respected names like Rolex (1951), CHANEL (1954), L’Oréal (1957) and Sony (1958), Modern Home started to shine as an icon of prosperity and symbolic change while building strong relationships based on mutual trust with clients and brands alike, which still resonate today

Modern Home is proudly supporting the “Precision Medicine and the Future of Genomics (PMFG) Summit 2025” as a Gold Sponsor. L’Oréal, the world leader in dermocosmetics, will participate in the Summit with a dedicated booth showcasing its internationally renowned skincare brands recommended by healthcare professionals and distributed in medical outlets worldwide, including Vichy, La Roche-Posay, SkinCeuticals, and CeraVe.

Integrated Gulf Biosystems

Integrated Gulf Biosystems (IGB) delivers advanced life science solutions across Saudi Arabia, the United Arab Emirates, Qatar, Bahrain, Oman, Libya, Iraq, and India. The company supports research and diagnostic initiatives in oncology, infectious disease, reproductive health, forensics, food safety, transplant diagnostics, biobanking, and laboratory automation.

IGB offers end-to-end expertise in the design, engineering, and implementation of turnkey laboratories, managing every phase from concept to commissioning. Backed by a team of more than 200 professionals and a leadership group with over 100 years of combined experience, IGB prioritizes customer focus, operational rigor, and technology-driven service delivery to enable reliable and efficient scientific and diagnostic outcomes.

IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and accelerate innovations. With approximately 90,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

TherapAI

TherapAI® is an AI-driven healthcare innovation company redefining the future of personalized and preventive medicine, by integrating genomic profiling, biological and clinical data with advanced artificial intelligence. TherapAI® technology can accurately identify individual susceptibilities to a wide range of health conditions including obesity, diabetes, cancer, and factors influencing longevity enabling early risk detection. TherapAI® delivers actionable insights that transform how individuals and healthcare providers manage health risks.

GeneDX

GeneDx (Nasdaq: WGS) is the global leader in rare disease diagnosis, transforming medicine by making genomics the starting point for health, not the last resort. Through the power of GeneDx Infinity™—the largest rare disease dataset built from millions of tests—and our recent integration with Fabric Genomics, we’re bringing advanced AI and scalable data analysis together to deliver faster, more precise answers for patients. This combined foundation accelerates clinical insight, supports discovery, and moves the standard of care to proactive healthcare.

EveryONE Medicines

EveryONE Medicines delivers individualized precision therapeutics, customized to the unique pathogenic genetic mutation of patients.

Mass General Brigham

Mass General Brigham, based in Boston, Massachusetts, offers access to world-class, integrated health care led by leading Harvard-affiliated physicians. Our top-ranked hospitals are recognized globally for pioneering research and groundbreaking therapies in gene and cell therapy, precision medicine, and genomics. We are the provider of choice for subspecialty and integrated care to patients worldwide. Through long-standing partnerships, we collaborate to transform healthcare delivery and innovation, enhancing the health and well-being of local communities.

Connect with our international team to learn more: www.MassGeneralBrigham.org/international 

Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 120 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore’s technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

Oxford Nanopore devices sequence DNA and RNA directly and sequence short to ultra-long fragments of DNA, for a truly comprehensive picture of the genome. Data is streamed in real-time and can enable rapid insights. The technology is fully scalable — from pocket-sized to ultra-high throughput devices.

Google Cloud

Dell Technologies

ABC

Khalid Scientific Co. W.L.L.

Khalid Scientific Co. W.L.L. was established in 1979 with a passionate desire to adequately provide medical, laboratory and pharmaceutical solutions together with services of the highest quality.

KSC is a diversified company housing ten distinct divisions – Laboratory, Imaging, Medical Equipment, Cardiology, Consumables, Healthcare Facilities, Surgical, Projects and Service under its sales and operations where each has its own specific field and scope, and functions as a team to make better care possible for patients.

Together with our leading Healthcare Providers, valued Channel Partners and Clients – KSC provides our valuable customers the ultimate innovative solutions and a wide range of medical products safely and cost-effectively.

New Concept Pharma

Mannai

Mannai ICT Networking and ELV, a subsidiary of Mannai Corporation Group Qatar, is a leading ICT solutions provider in Qatar and beyond, delivering an extensive portfolio of cutting-edge technologies and services designed to drive innovation and efficiency.

Specializing in AI-driven applications, advanced data infrastructure, cybersecurity, managed services, collaboration tools, surveillance systems, smart building technologies, and IoT integration, Mannai ICT Networking and ELV caters to the diverse needs of businesses across industries.

The company’s expertise extends to delivering tailored solutions that optimize operations, enhance security, and support digital transformation. With a strong focus on cybersecurity, Mannai ICT Networking and ELV provides state-of-the-art solutions to safeguard digital assets, ensuring robust protection against evolving threats.

Backed by strategic global partnerships and leading global ICT brands, industry-leading certifications, and a commitment to excellence, Mannai ICT Networking and ELV stands at the forefront of technology innovation.

Trusted by enterprises of all scales, Mannai ICT Networking and ELV continues to empower businesses with scalable, reliable, and future-ready solutions for a rapidly changing digital landscape.

Zetta Genomics

At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.

We are pioneers in genomics with over a decade of experience – handling complex and large genomic data is at the heart of what we do. Born from the prestigious University of Cambridge and honed through our contributions to Genomics England’s landmark 100,000 Genomes Project, XetaBase leverages cutting-edge, real-world tested technology to deliver powerful genomic analysis solutions.

As a unified platform for both research and clinical applications, XetaBase enables us to collaborate with healthcare systems, life sciences companies, research institutions and global health-tech innovators, ensuring that the promise of precision medicine becomes a reality for all.

CHOP

Gold Sponsor / Knowledge Partner

Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine.  Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.

World-class Care

Our physicians are internationally recognized experts in every pediatric specialty, including precision medicine, genomics, oncology/hematology, cardiac care, fetal medicine, orthopedics, neonatology, endocrinology, gastroenterology and urology.  Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children:  for the 17^th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States.

U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.

Innovation and education

A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers.  Celebrating its 100^th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).

Eastgate Medical Service

Eastgate Medical Services, a customer-centric distributor of medical devices and pharmaceuticals, Eastgate Medical Services is committed to supplying top-tier brands and products.

Through strategic partnerships and a focus on long-term relationships, we aim to lead the industry by delivering exceptional value to our clients.

Our goal is simple: to ensure customer satisfaction by offering the best for the Patient in terms competitive pricing, superior quality, and mutual growth opportunities.

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients. With headquarters in Rostock, Germany, and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families.

CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.

Eastgate Medical Services, a customer-centric distributor of medical devices and pharmaceuticals, partners with CENTOGENE, a rare disease company dedicated to transforming genetic data into medical solutions. Together, we offer innovative solution and personalized care, ensuring superior outcomes for for patients with rare diseases and their families.

Centogene

Al Suwaidi Trading EST

Since 1982, Mr. Ali Al Suwaidi, founder and Chairman of Ali Al Suwaidi Trading Establishment "ASTE", has dedicated himself to enhancing Qatar’s healthcare sector. Over the past 42 years, ASTE has built a strong reputation for the reliable distribution of high-quality medical, laboratory, and pharmaceutical products, each aligning with stringent quality standards.

Today, Ali Al Suwaidi Trading "AST" enters an exciting new chapter with a rebranding, introducing a new logo that symbolizes our enduring commitment. With this, we are also proud to welcome our new CEO, Mrs. Shaikha Ali Al-Suwaidi who will continue her father’s legacy under his guidance. Mrs. Sheikha brings with herself a personal mission, ensuring the refinement of operations and procedures, while staying true to the legacy her father has instilled in the company for decades past.

We remain committed to serving healthcare providers, laboratories, and pharmacies with precision, reliability, and care as a trusted partner in Qatar, with patient well-being as our first priority.

GenQA

GenQA - Genomic Quality Assessment, is an ISO17043-2023 accredited global EQA provider offering a wide repertoire of EQAs/Proficiency Testing (PT) ) to laboratories and clinicians world-wide to meet their quality and accreditation needs and ensure high quality end to end genomic services. Areas covered include Genomic and Inherited Disorders, PGT, Reproductive Genetics (including NIPT), NGS, Molecular Newborn Screening, Haematological Neoplasms, Molecular Pathology, Sample Handling, DNA extractions, Clinical Genetics/Genetic Counselling. GenQA also offers competency assessments for individuals through our educational platform, GENie focussing on classification of variants and ISCN/HGVS nomenclature.

SeqOne

SeqOne is a leading European provider of AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Its cloud-based platform transforms complex genomic data into fast, precise, and actionable insights, supporting molecular labs in delivering life-saving diagnoses and treatments. The SeqOne Platform is CE-IVD Class C certified under IVDR as an in vitro diagnostic medical device. Driven by the vision of personalized medicine for every patient, everywhere, SeqOne is scaling the future of genomic medicine—one lab at a time.

Cytomate Solutions and Services

Established in Doha, Qatar, Cytomate has rapidly risen as a beacon of innovation in cybersecurity, showcasing its global competitiveness and its distinctive Qatari identity. The company’s birth emerged from a recognition of the increasing complexities of cyber threats and a profound determination to counteract them. The invaluable support and investment from Qatar Development Bank have been instrumental in propelling Cytomate to the forefront of its industry. The company now proudly stands as the only Qatari entity providing the Breach and Attack Simulation (BAS) solution, a cutting-edge tool empowered by Artificial Intelligence (AI), specifically SnipeX.

StraalPharma B.V.

Founded in 2018 in the Netherlands, StraalPharma B.V. specializes in addressing medication shortages for hospitals. We source from reputable companies across the globe, including the USA, UK, Europe, Turkey, Switzerland, Australia, Canada, and more, to provide hospitals with the medications they need.

Our approach is focused on meeting specific demands rather than maintaining a standard product list, ensuring we're responsive to the immediate needs of healthcare providers.

We adhere to strict storage and transportation standards, holding WDA and GDP licenses that are published on Eudra GMDP for quality assurance.

Gulf Scientific Corporation

Founded in 1990, Gulf Scientific Corporation (GSC) is headquartered in Dubai, United Arab Emirates with four regional offices and a number of distribution outlets across the Middle East.

GSC has established strategic partnerships with market leaders that include Merck, Thermo Fisher Scientific, DNA Script, and Waters among others to ensure that clients have the best available resources to meet their critical laboratory needs.

With an unrivaled support structure that includes manufacturer-certified service and training centers, GSC is the preferred choice for companies in a wide range of industries including, clinical, pharmaceutical, food and beverage, oil and gas, environmental, and others.

GOSH

Great Ormond Street Hospital for Children

CHOP

Gold Sponsor / Knowledge Partner

Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine.  Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.

World-class Care

Our physicians are internationally recognized experts in every pediatric specialty, including precision medicine, genomics, oncology/hematology, cardiac care, fetal medicine, orthopedics, neonatology, endocrinology, gastroenterology and urology.  Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children:  for the 17^th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States.

U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.

Innovation and education

A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers.  Celebrating its 100^th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).

Zulal Wellness Resort

Zulal Wellness Resort is the Middle East’s largest immersive wellness destination and the world’s first full-immersion resort to blend Traditional Arabic & Islamic Medicine with holistic health and wellbeing practices. Located in northern Qatar and operated by Chiva-Som, Zulal offers a transformative journey of healing and restoration through personalized wellness programs, natural therapies, and mindful nutrition. The resort caters to both adults and families, providing a unique space where guests can rejuvenate, reconnect, and embrace a healthier lifestyle, making it a pioneering wellness destination not only in Qatar but across the region.

Visit Qatar

Mr. Valet

Blumen

Agrico

Katara Genomes Biodiversity

Katara Biodiversity Genomes Program (KBGP) is a pioneering initiative by the Katara Cultural Village Foundation, dedicated to safeguarding Qatar’s rich biodiversity through the power of advanced genomic science. By focusing on species of cultural, ecological, and conservation importance, KBGP aims to position Qatar as a regional leader in the rapidly expanding field of biodiversity genomics.
Leveraging state-of-the-art genomic technologies and world-class research infrastructure, the program delivers high-impact scientific outputs that not only serve national priorities but also contribute meaningfully to the global understanding of biodiversity.
Beyond research, KBGP is deeply committed to building national capacity. The program trains local scientists, supports students through workshops and internships, and helps cultivate the next generation of Qatari experts in genomics and conservation.
With a vision that fuses scientific innovation with deep cultural roots, KBGP strives to maintain a harmonious balance between conserving nature and preserving culture.